Education
About Us
Working with TipRanks
Follow Us
Cytophage Technologies Ltd. (TSE:CYTO)
:CYTO
CYTO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.13 - C$0.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)58.53K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,827,995
10 Day Avg. Volume17,439
30 Day Avg. Volume58,531
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
1.17% Insiders
―
Mutual Funds
― Other Institutional Investors
98.83% Public Companies and
Individual Investors
CYTO FAQ
What was Cytophage Technologies Ltd.’s price range in the past 12 months?
Cytophage Technologies Ltd. lowest stock price was C$0.13 and its highest was C$0.40 in the past 12 months.
What is Cytophage Technologies Ltd.’s market cap?
Currently, no data Available
When is Cytophage Technologies Ltd.’s upcoming earnings report date?
Cytophage Technologies Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 66 days.
How were Cytophage Technologies Ltd.’s earnings last quarter?
Currently, no data Available
Is Cytophage Technologies Ltd. overvalued?
According to Wall Street analysts Cytophage Technologies Ltd.’s price is currently Overvalued.
Does Cytophage Technologies Ltd. pay dividends?
Cytophage Technologies Ltd. does not currently pay dividends.
What is Cytophage Technologies Ltd.’s EPS estimate?
Cytophage Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cytophage Technologies Ltd. have?
Cytophage Technologies Ltd. has 45,827,995 shares outstanding.
What happened to Cytophage Technologies Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cytophage Technologies Ltd.?
Currently, no hedge funds are holding shares in TSE:CYTO
Company Description
Cytophage Technologies Ltd.
Cuspis Capital III Ltd is a capital pool company.
Technical Analysis
Medicenna Therapeutics Corp
―
Biocure Technology Inc
―
Algernon Pharmaceuticals
―
Waverley Pharma
―
Eupraxia Pharmaceuticals
―